COVID-19 Clinical Trials

A listing of COVID-19 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1597 clinical trials
Featured trial
Caregiver Burden and Adaptation of Dementia Relatives During COVID-19

This mixed-method study aims to explore the burden level among informal caregivers of relatives with dementia during the COVID-19 pandemic and discover their adaptation methods. With this in

Online studies
Accepts healthy volunteers
  • 152 views
  • 23 Sep, 2022
  • 1 location
  • Online study
Featured trial
Genetics in Alzheimer Disease Related Dementias

The Alzheimer Disease Related Dementia studies are looking for participants to better understand the genetic factors contributing to frontotemporal dementia or dementia with Lewy bodies. Genetics helps us improve the knowledge on biology, diagnosis and future therapies for these diseases.

Online studies
Accepts healthy volunteers
  • 1123 views
  • 23 Sep, 2022
  • 1 location
  • Online study
Featured trial
A Randomized Double-blind Placebo-controlled Parallel Group Study Assessing the Efficacy and Safety of Dupilumab in Patients With Allergic Fungal Rhinosinusitis (AFRS)  

Primary Objective: To evaluate the ability of dupilumab to reduce the need for rescue therapy with systemic corticosteroids (SCS) or surgery of AFRS in patients with AFRS who previously have had sino-nasal surgery Secondary Objectives: To evaluate the efficacy of treatment with dupilumab to reduce sinus opacification in a population …

  • 60 views
  • 09 Nov, 2022
  • 5 locations
Featured trial
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose Ranging Study to Assess the Efficacy, Safety, and Tolerability of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma (TIDE-asthma)  

This is a parallel, Phase 2, global, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, four-arms study for treatment. The purpose of this study is to assess the efficacy, safety, and tolerability of add-on therapy with amlitelimab in adult participants with moderate-to-severe asthma. Study details include: The study duration (per participant) will be …

  • 6 views
  • 17 Nov, 2022
  • 5 locations
Featured trial
Randomized, Open Label Phase 3 Study of SAR408701 Versus Docetaxel in Previously Treated Metastatic Non- Squamous Non-Small Cell Lung Cancer Patients With CEACAM5 Positive Tumors (CARMEN-LC03)  

Primary Objectives: Study is designed with two primary endpoints that will be analyzed on randomized participants at the time of the cutoff date for each given analysis (progression free survival [PFS] and overall survival [OS]). Study success is defined either on PFS or OS The primary objective is to determine …

  • 132 views
  • 17 Nov, 2022
  • 5 locations
Featured trial
Dupilumab in CRSsNP (Liberty CRSsNP ORION)  

Primary Objective: Part A and B: To evaluate the efficacy of dupilumab as assessed by the reduction at Week 24 in sinus opacification on computerized tomography (CT) scan and sinus total symptom score (sTSS) compared to placebo Secondary Objectives: Part A To evaluate the efficacy of dupilumab as assessed by …

antibiotics
acute sinusitis
asthma
obstruction
rhinorrhea
  • 20 views
  • 09 Nov, 2022
  • 9 locations
Featured trial
Covid-19 Treatment P0019

If you have mild to moderate COVID you may be eligible to participate in study for a covid treatment. Receive up to $865 in compensation. Must be 18-65 years old. Generally Healthy.

  • 0 views
  • 09 Nov, 2022
  • 1 location
Featured trial
COVID-19 Treatment Outpatient

People with COVID-19 are asked to participate in a research study being conducted by Montefiore Medical Center.

  • 124 views
  • 06 Aug, 2021
  • 1 location
Featured trial
Covid-19 Pill Treatment S0018

This is a study for the treatment of COVID-19 administered orally by pill. Receive up to $1,750 in compensation and study related care. Must be 18 - 64 years old. 

  • 13 views
  • 08 Sep, 2022
  • 1 location
Featured trial
Covid-19 Mild to Moderate Treatment

If you have mild to moderate Covid you may be eligible to participate in study for a mild to moderate Covid treatment. Receive up to $2,175 in compensation. Must be 18-50 years old and a non-smoker. Generally Healthy. Compensation: - Compensation from up to $2,175- Study related care at no …

Accepts healthy volunteers
  • 6 views
  • 20 May, 2022
  • 1 location